Ascentage is looking to use the IPO proceeds to advance its Phase III candidates for chronic or small lymphocytic leukemia ...

Sionna Therapeutics (SION), which is developing drugs to treat cystic fibrosis, has filed to raise $100M through an initial public offering. While Sionna (SION) didn't disclose terms in its SEC filing ...

IPO activity seems to have picked up in the U.S. with investors expecting the new Trump government to further its ...

While some analysts expect the 2025 IPO market to be relatively cool in the near-term, others anticipate more bids than in ...

Formed in 2019, Sionna's most recent financing was a $182 million third round that closed last year, which followed a $111 ...

Sionna Therapeutics and Odyssey Therapeutics join Metsera and Maze in filing for IPOs, with Sionna focused on cystic fibrosis ...

The startups are the fourth and fifth drugmakers to file for initial stock sales since late December — the most IPO activity ...

Odyssey Therapeutics and Sionna Therapeutics have filed IPO paperwork, swelling the pack of startups that will provide an ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

New Canaan 5, West Haven/Sacred Heart 0 West Haven/Sacred Heart 0-0-0 0 New Canaan 3-2-0 5 NC: Serena O’Connor 3g, Maddie ...

Sionna Therapeutics and Odyssey Therapeutics on Friday joined a queue of young developers to publicly reveal IPO plans this ...

Hello everybody and welcome to our live coverage of the All-Ireland Intermediate Club Hurling Championship final between ...